Hao Yan-Ping, Qiu Jing-Hui, Zhang Dong-Bo, Yu Cheng-Gong
1 Department of Gastroenterology, Nanjing Drum Tower Hospital, Clinical college of Nanjing Medical University, Nanjing, China.
2 Department of Gastroenterology, The First People's Hospital of Yancheng, Yancheng, Jiangsu, China.
Tumour Biol. 2017 Jun;39(6):1010428317699798. doi: 10.1177/1010428317699798.
Gastric cancer remains the third leading cause of cancer-related mortality worldwide, and proliferation of gastric cancer represents the major reason for its poor prognosis. Recent evidence indicates that long non-coding RNAs play crucial roles in development and progression of gastric cancer. Long non-coding RNA differentiation antagonizing non-protein coding RNA is upregulated in hepatic cell carcinoma, but the role of lncRNA differentiation antagonizing non-protein coding RNA in gastric cancer has not been explored. In this article, we found that differentiation antagonizing non-protein coding RNA is also upregulated in gastric cancer. Experiments revealed that silencing differentiation antagonizing non-protein coding RNA significantly inhibited gastric cancer cell proliferation in vitro and in vivo. Overexpression of differentiation antagonizing non-protein coding RNA notably increases gastric cancer cell proliferation. From RNA-seq and gene ontology annotations, we found that differentiation antagonizing non-protein coding RNA influences the gene expression programs in cell metabolic and cycle process. Taken together, our findings suggest that the long non-coding RNA differentiation antagonizing non-protein coding RNA promotes the proliferation of gastric cancer and is a potential prognostic biomarker and therapeutic target in gastric cancer.
胃癌仍是全球癌症相关死亡的第三大主要原因,而胃癌的增殖是其预后不良的主要原因。最近的证据表明,长链非编码RNA在胃癌的发生和发展中起着关键作用。长链非编码RNA分化拮抗非蛋白质编码RNA在肝癌中上调,但lncRNA分化拮抗非蛋白质编码RNA在胃癌中的作用尚未被探索。在本文中,我们发现分化拮抗非蛋白质编码RNA在胃癌中也上调。实验表明,沉默分化拮抗非蛋白质编码RNA在体外和体内均显著抑制胃癌细胞增殖。分化拮抗非蛋白质编码RNA的过表达显著增加胃癌细胞增殖。通过RNA测序和基因本体注释,我们发现分化拮抗非蛋白质编码RNA影响细胞代谢和周期过程中的基因表达程序。综上所述,我们的研究结果表明,长链非编码RNA分化拮抗非蛋白质编码RNA促进胃癌增殖,是胃癌潜在的预后生物标志物和治疗靶点。